JPS5919550B2 - (E)-2-[p-(β-2-thienylvinyl)phenyl]propionic acid and its production method - Google Patents
(E)-2-[p-(β-2-thienylvinyl)phenyl]propionic acid and its production methodInfo
- Publication number
- JPS5919550B2 JPS5919550B2 JP1947876A JP1947876A JPS5919550B2 JP S5919550 B2 JPS5919550 B2 JP S5919550B2 JP 1947876 A JP1947876 A JP 1947876A JP 1947876 A JP1947876 A JP 1947876A JP S5919550 B2 JPS5919550 B2 JP S5919550B2
- Authority
- JP
- Japan
- Prior art keywords
- thienylvinyl
- phenyl
- propionic acid
- acid
- solvent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 title claims description 26
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 title claims description 17
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 title claims description 15
- 235000019260 propionic acid Nutrition 0.000 title claims description 13
- 238000004519 manufacturing process Methods 0.000 title claims description 8
- -1 glycidic acid ester Chemical class 0.000 claims description 15
- KWOLFJPFCHCOCG-UHFFFAOYSA-N Acetophenone Chemical compound CC(=O)C1=CC=CC=C1 KWOLFJPFCHCOCG-UHFFFAOYSA-N 0.000 claims description 12
- 239000003513 alkali Substances 0.000 claims description 10
- 239000003795 chemical substances by application Substances 0.000 claims description 8
- 239000002253 acid Substances 0.000 claims description 6
- 239000007864 aqueous solution Substances 0.000 claims description 6
- 239000000126 substance Substances 0.000 claims description 3
- 150000001242 acetic acid derivatives Chemical class 0.000 claims 1
- 125000002485 formyl group Chemical class [H]C(*)=O 0.000 claims 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 25
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 18
- 239000002904 solvent Substances 0.000 description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 16
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 15
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 15
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 13
- 238000000034 method Methods 0.000 description 13
- 238000006460 hydrolysis reaction Methods 0.000 description 10
- NDVLTYZPCACLMA-UHFFFAOYSA-N silver oxide Chemical compound [O-2].[Ag+].[Ag+] NDVLTYZPCACLMA-UHFFFAOYSA-N 0.000 description 10
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 9
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 9
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 8
- 230000007062 hydrolysis Effects 0.000 description 8
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 7
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 6
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- 238000010438 heat treatment Methods 0.000 description 5
- 238000010992 reflux Methods 0.000 description 5
- 229910001923 silver oxide Inorganic materials 0.000 description 5
- 229910052717 sulfur Inorganic materials 0.000 description 5
- 239000011593 sulfur Substances 0.000 description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 4
- 239000003960 organic solvent Substances 0.000 description 4
- 239000002244 precipitate Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 229910052708 sodium Inorganic materials 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 3
- 239000002260 anti-inflammatory agent Substances 0.000 description 3
- 229940121363 anti-inflammatory agent Drugs 0.000 description 3
- 239000002585 base Substances 0.000 description 3
- 150000003857 carboxamides Chemical class 0.000 description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 239000012046 mixed solvent Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 229920001021 polysulfide Polymers 0.000 description 3
- 239000005077 polysulfide Substances 0.000 description 3
- 150000008117 polysulfides Polymers 0.000 description 3
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 3
- 230000035484 reaction time Effects 0.000 description 3
- 150000003335 secondary amines Chemical class 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- ZFFBIQMNKOJDJE-UHFFFAOYSA-N 2-bromo-1,2-diphenylethanone Chemical compound C=1C=CC=CC=1C(Br)C(=O)C1=CC=CC=C1 ZFFBIQMNKOJDJE-UHFFFAOYSA-N 0.000 description 2
- RLQZIECDMISZHS-UHFFFAOYSA-N 2-phenylcyclohexa-2,5-diene-1,4-dione Chemical compound O=C1C=CC(=O)C(C=2C=CC=CC=2)=C1 RLQZIECDMISZHS-UHFFFAOYSA-N 0.000 description 2
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- NBBJYMSMWIIQGU-UHFFFAOYSA-N Propionic aldehyde Chemical compound CCC=O NBBJYMSMWIIQGU-UHFFFAOYSA-N 0.000 description 2
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 2
- WGLPBDUCMAPZCE-UHFFFAOYSA-N Trioxochromium Chemical compound O=[Cr](=O)=O WGLPBDUCMAPZCE-UHFFFAOYSA-N 0.000 description 2
- 238000005903 acid hydrolysis reaction Methods 0.000 description 2
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 2
- 125000000217 alkyl group Chemical group 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 150000001450 anions Chemical class 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 239000000679 carrageenan Substances 0.000 description 2
- 229940113118 carrageenan Drugs 0.000 description 2
- 235000010418 carrageenan Nutrition 0.000 description 2
- 229920001525 carrageenan Polymers 0.000 description 2
- 239000003518 caustics Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 229910001873 dinitrogen Inorganic materials 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 239000012454 non-polar solvent Substances 0.000 description 2
- 239000007800 oxidant agent Substances 0.000 description 2
- FDPIMTJIUBPUKL-UHFFFAOYSA-N pentan-3-one Chemical compound CCC(=O)CC FDPIMTJIUBPUKL-UHFFFAOYSA-N 0.000 description 2
- 239000002798 polar solvent Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 229910000104 sodium hydride Inorganic materials 0.000 description 2
- 239000012312 sodium hydride Substances 0.000 description 2
- WBQTXTBONIWRGK-UHFFFAOYSA-N sodium;propan-2-olate Chemical compound [Na+].CC(C)[O-] WBQTXTBONIWRGK-UHFFFAOYSA-N 0.000 description 2
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 2
- IAWWAVGUKRSONG-UHFFFAOYSA-N 2,4-dimethyl-2-phenylpentanoic acid Chemical compound CC(C)CC(C)(C(O)=O)C1=CC=CC=C1 IAWWAVGUKRSONG-UHFFFAOYSA-N 0.000 description 1
- SEDGGCMDYFKAQN-UHFFFAOYSA-N 3-methyloxirane-2-carboxylic acid Chemical compound CC1OC1C(O)=O SEDGGCMDYFKAQN-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- BDAGIHXWWSANSR-UHFFFAOYSA-N Formic acid Chemical compound OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 1
- 244000027321 Lychnis chalcedonica Species 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229910001854 alkali hydroxide Inorganic materials 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 229910000102 alkali metal hydride Inorganic materials 0.000 description 1
- 150000008046 alkali metal hydrides Chemical class 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 229910001860 alkaline earth metal hydroxide Inorganic materials 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- 238000005904 alkaline hydrolysis reaction Methods 0.000 description 1
- 150000004703 alkoxides Chemical class 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 229910052788 barium Inorganic materials 0.000 description 1
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 1
- RQPZNWPYLFFXCP-UHFFFAOYSA-L barium dihydroxide Chemical compound [OH-].[OH-].[Ba+2] RQPZNWPYLFFXCP-UHFFFAOYSA-L 0.000 description 1
- 229910001863 barium hydroxide Inorganic materials 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical group BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 235000019987 cider Nutrition 0.000 description 1
- 229940011182 cobalt acetate Drugs 0.000 description 1
- QAHREYKOYSIQPH-UHFFFAOYSA-L cobalt(II) acetate Chemical compound [Co+2].CC([O-])=O.CC([O-])=O QAHREYKOYSIQPH-UHFFFAOYSA-L 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 238000006114 decarboxylation reaction Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 1
- SBZXBUIDTXKZTM-UHFFFAOYSA-N diglyme Chemical compound COCCOCCOC SBZXBUIDTXKZTM-UHFFFAOYSA-N 0.000 description 1
- 229910001882 dioxygen Inorganic materials 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 125000004185 ester group Chemical class 0.000 description 1
- 150000002168 ethanoic acid esters Chemical class 0.000 description 1
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 1
- VEUUMBGHMNQHGO-UHFFFAOYSA-N ethyl chloroacetate Chemical compound CCOC(=O)CCl VEUUMBGHMNQHGO-UHFFFAOYSA-N 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- OTGHWLKHGCENJV-UHFFFAOYSA-N glycidic acid Chemical class OC(=O)C1CO1 OTGHWLKHGCENJV-UHFFFAOYSA-N 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 239000011630 iodine Chemical group 0.000 description 1
- 229910052740 iodine Chemical group 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 229910000103 lithium hydride Inorganic materials 0.000 description 1
- AHNJTQYTRPXLLG-UHFFFAOYSA-N lithium;diethylazanide Chemical compound [Li+].CC[N-]CC AHNJTQYTRPXLLG-UHFFFAOYSA-N 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 238000007069 methylation reaction Methods 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 229910000105 potassium hydride Inorganic materials 0.000 description 1
- NTTOTNSKUYCDAV-UHFFFAOYSA-N potassium hydride Chemical compound [KH] NTTOTNSKUYCDAV-UHFFFAOYSA-N 0.000 description 1
- 239000012286 potassium permanganate Substances 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000007363 ring formation reaction Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- ODZPKZBBUMBTMG-UHFFFAOYSA-N sodium amide Chemical compound [NH2-].[Na+] ODZPKZBBUMBTMG-UHFFFAOYSA-N 0.000 description 1
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Landscapes
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
【発明の詳細な説明】
本発明は抗炎症、鎮痛、下熱、血小板凝集阻害作用を有
する一般式(I)見c■c/HcH。DETAILED DESCRIPTION OF THE INVENTION The present invention provides compounds of the general formula (I) c■c/HcH, which have anti-inflammatory, analgesic, fever-lowering, and platelet aggregation inhibiting effects.
゜”’H’ 0とHCOOH
で示される(l−2−〔p−(β−2−チエニルビニル
)フェニル〕プロピオン酸及びその製造方法に関するも
のである。The present invention relates to (l-2-[p-(β-2-thienylvinyl)phenyl]propionic acid represented by ゜"'H' 0 and HCOOH and a method for producing the same.
本発明者らは、新しい抗炎症剤の開発を目的として新規
医薬品の研究を行つてきたが、この度抗炎症剤として秀
れた作用を有する(D−2−〔p−(β−2−チエニル
ビニル)フェニル〕プロピオン酸を発明した。The present inventors have been conducting research on new pharmaceuticals with the aim of developing new anti-inflammatory agents, and now we have discovered that D-2-[p-(β-2-thienyl) has an excellent effect as an anti-inflammatory agent. Invented vinyl)phenyl]propionic acid.
即ち、本発明の化合物は抗炎症剤で有用なイソブチルフ
ェニルプロピオン酸に対し、カラゲニン浮腫法による抗
炎症作用の測定では約1〜2倍、フェニルキノンリッチ
シダ法による鎮痛作用測定では約3倍の効果を示し、又
毒性も低いものである。本発明の田−2−〔p−β−2
−チエニルビニル)フェニル〕プロピオン酸は次の2つ
の方法で製造することができる。(1)
見c■/H(■)
□C0CH3
/
X−CH2COOR011)
門■を;メ:。That is, the compound of the present invention has about 1 to 2 times the anti-inflammatory effect measured by the carrageenan edema method, and about 3 times the analgesic effect measured by the phenylquinone rich cider method, compared to isobutylphenylpropionic acid, which is useful as an anti-inflammatory agent. It is effective and has low toxicity. Field-2-[p-β-2 of the present invention
-thienylvinyl)phenyl]propionic acid can be produced by the following two methods. (1) See c■/H (■) □C0CH3 / X-CH2COOR011) Gate ■; Me:.
0、・
アルカリ
〔但し、式中Rは低級アルキル基、Mはアルカリ又は1
/2アルカリ土類金属、Xは塩素、臭素、ヨウ素を表わ
す。0, alkali [wherein R is a lower alkyl group, M is an alkali or 1
/2 alkaline earth metal, X represents chlorine, bromine, or iodine.
〕を表わす〕
(1)の方法
第]工程
(ト)−p−(β−2−チエニルビニル)アセトフエノ
ン()に、窒素などの不活性大気中に於て無水条件下、
アルカリ縮合剤を存在せしめて、α−ハロゲン化酢酸エ
ステノ噌を反応せしめる。[representing]] Method of (1) Step (g)-p-(β-2-thienylvinyl)acetophenone () is treated under anhydrous conditions in an inert atmosphere such as nitrogen,
In the presence of an alkaline condensing agent, the α-halogenated acetic acid ester is reacted.
(ダルツエン縮合)
アルカリ縮合剤としては、ソーダアミド、カリウムアミ
ド、水素化ナトリウム、ナトリウムメトキシド、ナトリ
ウムイソプロポキシド、カリウム一t−ブトキシド、ジ
エチルアミドリチウムなどが挙げられる。(Dalzene Condensation) Examples of the alkaline condensing agent include soda amide, potassium amide, sodium hydride, sodium methoxide, sodium isopropoxide, potassium t-butoxide, and lithium diethylamide.
溶媒としてはメタノール、エタノール、イソプロパノー
ル、ブタノールなどのアルカノール類、エーテル、また
はトルエン、キシレンなどの炭化水素類、軽油が使用さ
れる。これらの縮合剤及び溶媒のうち、イソプロパノー
ル中、ナトリウムイソプロポキシドあるいはt−ブタノ
ール中、カリウム一t−ブトキシドを使用するのが好ま
しい。反応温度はO℃から溶媒の還流温度の範囲である
が、最適温度は使用される齢剤及び溶媒によつて異なり
、O℃〜室温付近が好ましい。α−ハロゲン化酢酸エス
テル(至)の島は、メチル、エチル、プロピル、イソプ
ロピル、ブチル、t−ブチルなどの低級アルキル基を表
わす。このエステル基R3が、アルコキシド縮合剤を調
製するアルカノールと同一であれば、反応生成物は充分
に純粋なものとすることができる。第2工程
水分解することにより、一般式(至)の塩を生成せしめ
る。As the solvent, alkanols such as methanol, ethanol, isopropanol and butanol, ether, hydrocarbons such as toluene and xylene, and light oil are used. Among these condensing agents and solvents, it is preferred to use isopropanol, sodium isopropoxide, or potassium t-butoxide in t-butanol. The reaction temperature ranges from 0°C to the reflux temperature of the solvent, but the optimum temperature varies depending on the aging agent and solvent used, and is preferably from 0°C to around room temperature. The α-halogenated acetate ester represents a lower alkyl group such as methyl, ethyl, propyl, isopropyl, butyl, t-butyl, etc. If this ester group R3 is the same as the alkanol from which the alkoxide condensing agent is prepared, the reaction product can be sufficiently pure. In the second step, by water decomposition, a salt of general formula (2) is produced.
用いるアルカリとしては水酸化ナトリウム、水酸化カリ
ウムなどの水酸化アルカリ、水酸化カルシウム、水酸化
バリウムなどのアルカリ土類金属の水酸化物などである
。このナトリウム、カリウム及びカルシウム塩類は、エ
ステルの加水分解生成物の代表的なものであり、水溶液
からの塩析は水性アルカノール中の沈澱によつて単離さ
せることができる。第3工程
単離したグリシド酸塩(V)をPH6〜8の水溶液中、
窒素ガスのような不活性大気中に於て90〜140℃、
好ましくは110〜120℃で3〜6時間加熱還流する
と、脱炭酸及び閉環反応し、アルデヒド化合物(ロ)が
得られる。Examples of the alkali used include alkali hydroxides such as sodium hydroxide and potassium hydroxide, and alkaline earth metal hydroxides such as calcium hydroxide and barium hydroxide. The sodium, potassium and calcium salts are representative of the hydrolysis products of the esters and can be isolated from aqueous solutions by precipitation in aqueous alkanols. 3rd step: The isolated glycidate salt (V) is added to an aqueous solution with a pH of 6 to 8.
90-140℃ in an inert atmosphere such as nitrogen gas,
Preferably, by heating and refluxing at 110 to 120°C for 3 to 6 hours, decarboxylation and ring closure reactions occur, yielding the aldehyde compound (b).
第4工程
アルデヒド化合物(ロ)の酸化を行ない目的の(匂一〔
p−(β−2−チエニルビニル)フエニル〕プロピオン
酸(1)を得る。The fourth step is to oxidize the aldehyde compound (b) to obtain the desired (Nouichi)
p-(β-2-thienylvinyl)phenyl]propionic acid (1) is obtained.
酸化剤としては、過マンガン酸カリウム、過酸化水素、
硝酸、無水クロム酸、酸化銀、酢酸コバルト触媒下で酸
素ガスなどをアルデヒド化合物(ロ)に対して2〜2.
5倍モル、好ましくは約2倍モル用いる。これらの酸化
剤のうち酸化銀が好ましい。溶媒としてはメタノール、
エタノール、プロパノール、イソプロパノールなどのア
ルカノール類と水の混合溶媒が用いられるが、好ましく
はエタノール水、メタノール一水の系である。Oxidizing agents include potassium permanganate, hydrogen peroxide,
Oxygen gas or the like is added to the aldehyde compound (b) for 2 to 2 hours under a catalyst of nitric acid, chromic anhydride, silver oxide, or cobalt acetate.
Use 5 times the mole, preferably about 2 times the mole. Among these oxidizing agents, silver oxide is preferred. Methanol as a solvent,
A mixed solvent of alkanols such as ethanol, propanol, and isopropanol and water is used, but a system of ethanol/water or methanol/water is preferable.
アルデヒド化合物(ロ)がそれらの溶媒に難溶性を示す
ときは、テトラヒドロフラン、ジオキサンなどを追加す
るとよい。酸化反応は、アルデヒド化合物(7)及び酸
化銀の水−エタノール混液にアルカリとして、例えば水
酸化ナトリウムの水溶液を滴下し、2〜3時間室温下、
撹拌後、酸化銀を濾別し、その濾液よりエタノールなど
の揮発性溶媒を留去し、エーテルのような水と混和しな
い溶剤で洗浄さへ得た水層を酸性化ののち、エーテノレ
、石油エーテノレ、n−ヘキサン、酢酸エチル、及びこ
れらの2種の混合溶媒など適当な溶剤で抽出し、蒸発乾
固後、軽油などにより晶出精製する。When the aldehyde compound (b) shows poor solubility in those solvents, tetrahydrofuran, dioxane, etc. may be added. For the oxidation reaction, an aqueous solution of sodium hydroxide, for example, as an alkali is added dropwise to a water-ethanol mixture of the aldehyde compound (7) and silver oxide, and the reaction is carried out at room temperature for 2 to 3 hours.
After stirring, silver oxide is filtered off, volatile solvents such as ethanol are distilled off from the filtrate, and the resulting aqueous layer is washed with a water-immiscible solvent such as ether. It is extracted with a suitable solvent such as ether, n-hexane, ethyl acetate, or a mixed solvent of these two, evaporated to dryness, and purified by crystallization using light oil or the like.
(2)の方法
第(1)工程で、第二級アミンとしてモルフオリンを用
いた場合、(匂−p−(β−2−チエニルビニル)アセ
トフエノン()にモルフオリンとイオウを加え、水浴上
または、油浴中常圧で加熱することによりカルボチオモ
ルホリド(a)が得られる。Method (2) When morpholin is used as the secondary amine in step (1), morpholin and sulfur are added to (p-(β-2-thienylvinyl)acetophenone) and placed on a water bath or Carbothiomorpholide (a) is obtained by heating in an oil bath at normal pressure.
溶媒としては殊に用いなくてもよいが、ピリジン、ジオ
キサンなどを補助の溶剤として用いてもよい。原料の(
ト)−p−(β−2−チエニルビニル)アセトフエノン
()に対し、モルフオリンは2〜5倍モル、好ましくは
2〜2.5倍モノレ、イオウは2〜3倍モル、好ましく
は2〜2.5倍モル程度用いる。反応温度は80〜15
0℃で、還流温度が好ましい。反応時間は3〜24時間
、好ましくは3〜4時間である。モルフオリンのかわり
にジメチルアミンまたはジエチルアミンなどの第二級ア
ミンを用いる場合には、原料の(ト)−p−(β−2−
チエニルビニル)アセトフエノン()にイオウ及び前記
アミン類を加え、閉管中で加熱すれば、カルボチアミド
(M[B,c)が得られる。Although it is not necessary to use any particular solvent, pyridine, dioxane, etc. may be used as an auxiliary solvent. of raw materials (
g)-p-(β-2-thienylvinyl)acetophenone (), morpholin is 2 to 5 times the mole, preferably 2 to 2.5 times the monomer, and sulfur is 2 to 3 times the mole, preferably 2 to 2 Use about .5 times the mole. Reaction temperature is 80-15
At 0°C, reflux temperature is preferred. The reaction time is 3 to 24 hours, preferably 3 to 4 hours. When using a secondary amine such as dimethylamine or diethylamine instead of morpholine, the (t)-p-(β-2-
If sulfur and the above-mentioned amines are added to thienylvinyl)acetophenone () and heated in a closed tube, carbothamide (M[B, c) is obtained.
反応温度は180〜200℃、反応時間は12〜24時
間である。The reaction temperature is 180-200°C and the reaction time is 12-24 hours.
第二級アミン類とイオウのかわりに多硫化アンモニウム
を用いる場合C人原料の(ト)−p−(β−2−チエル
ルビニル)アセトフエノン(1)に多硫化アンモニウム
を加え、閉管中200〜250℃,5〜24時間加熱す
ればカルボキサミド(MId)が得られる。When ammonium polysulfide is used instead of secondary amines and sulfur, ammonium polysulfide is added to the raw material (t)-p-(β-2-thierruvinyl)acetophenone (1), and the mixture is heated to 200 to 250°C in a closed tube. , carboxamide (MId) is obtained by heating for 5 to 24 hours.
多硫化アンモニウムは原料に対し、1.8〜2.0倍モ
ル用いる。溶媒としてはジオキサン、エタノール、ピリ
ジン等が使用される。これらのカルボチオアミド体(A
,b,c)またはカルボキサミド体(d)は単離するか
、若しくは単離せず、そのまま次の加水分解工程に用い
られる。加水分解工程(2)に於て、カルボチオアミド
体(A,b,c)は、塩酸などの強酸、または水酸化ナ
トリウム、水酸化カリウム等の強塩基により加水分解さ
れる。Ammonium polysulfide is used in an amount of 1.8 to 2.0 times the mole of the raw material. Dioxane, ethanol, pyridine, etc. are used as the solvent. These carbothioamides (A
, b, c) or the carboxamide compound (d) is isolated or not isolated and used as it is in the next hydrolysis step. In the hydrolysis step (2), the carbothioamide (A, b, c) is hydrolyzed with a strong acid such as hydrochloric acid or a strong base such as sodium hydroxide or potassium hydroxide.
第1工程の反応液に塩酸などの強酸または苛性アルカリ
を加えと第1工程に引き続き加水分解を行うか、pルボ
チオアミド体を単離した場合は、酢酸、ジオキサンなど
の溶媒に溶解して酸あるいはアルカリによる加水分解を
行う。加水分解反応後、酸による加水分解の場合は、溶
解補助剤として用いた酢酸、ジオキサン等の有機溶媒を
減圧留去し、濃縮後、水と混和しない溶剤、例えば、エ
ーテル、ベンゼン、クロロホルム、ジクロルメタン、石
油エーテルなどの有機溶媒にて抽出し、生成物を分離す
る。一方アルカリ加水分解の場合は、塩酸などで酸性化
したのち、析出する沈澱、または油状物を濾過または前
記水と混和しない溶媒にて抽出することにより分離する
。カルボキサミド体CVfXid)の加水分解6丸 メ
タノール、エタノールなどのアルコール性水溶液中に溶
かした前記苛性アルカリと共に加熱還流することによつ
て行い、反応終了後アルコールを留去し、濃縮液を氷冷
した塩酸中に投入し沈澱してくる遊離酸を分離精製する
。加水分解反応時間は約10〜24時間である。Hydrolysis can be carried out following the first step by adding a strong acid such as hydrochloric acid or a caustic alkali to the reaction solution in the first step, or if the p-rubothioamide compound is isolated, it can be dissolved in a solvent such as acetic acid or dioxane and treated with acid or Perform hydrolysis with alkali. After the hydrolysis reaction, in the case of acid hydrolysis, the organic solvent such as acetic acid or dioxane used as a solubilizing agent is distilled off under reduced pressure, and after concentration, a water-immiscible solvent such as ether, benzene, chloroform, or dichloromethane is added. The product is separated by extraction with an organic solvent such as petroleum ether. On the other hand, in the case of alkaline hydrolysis, after acidification with hydrochloric acid or the like, the precipitate or oily substance that precipitates is separated by filtration or extraction with a solvent immiscible with water. Hydrolysis of carboxamide (CVfXid) (6 circles) This was carried out by heating and refluxing the above caustic alkali dissolved in an alcoholic aqueous solution such as methanol or ethanol, and after the reaction was completed, the alcohol was distilled off, and the concentrated liquid was cooled with ice-cooled hydrochloric acid. The free acid that precipitates is separated and purified. Hydrolysis reaction time is approximately 10-24 hours.
次に第3工程のメチル化反応は、化合物鴇のカルボキシ
ル基をエステル化したのち、窒素気流中常温或いは冷却
時において、アルカリ縮合剤を極性または無極性溶媒中
で反応させると、対応する原料のアニオンが生成する。
該アニオンの生成は着色によつて容易に確認され、生成
時間は30分〜1時間を要する。アニオン生成気ハロゲ
ン化メチルを反応させるとα−モノアルキル化体が得ら
れる。用いる溶媒は極性溶媒としては、ジメチルホルム
アミド、ジメチルスルホキシド、液体アンモニアなど、
また無極性溶媒としては、ベンゼン、トルエン、n−ヘ
キサン、エーテル、ダイグライム、モノグライムなど、
或いはそれらの混合溶媒が用いられる。Next, in the third step, the methylation reaction, after esterifying the carboxyl group of the compound, the corresponding raw material is reacted with an alkaline condensing agent in a polar or non-polar solvent in a nitrogen stream at room temperature or during cooling. Anion is generated.
The generation of the anion is easily confirmed by coloring, and the generation time takes 30 minutes to 1 hour. When the anion-forming gas is reacted with methyl halide, an α-monoalkylated product is obtained. The solvent used is polar solvent such as dimethylformamide, dimethyl sulfoxide, liquid ammonia, etc.
In addition, non-polar solvents include benzene, toluene, n-hexane, ether, diglyme, monoglyme, etc.
Alternatively, a mixed solvent thereof may be used.
また、アルカリ縮合剤としては、水素化ナトリウム、水
素化カリウム、水素化リチウムなどのアルカリ金属水素
化物、ナトリウムアミド、カリウムアミドなどの金属ア
ミド類などが用いられる。得られた中間体のα−モyア
ルキル化体、即ちエステル体は酸またはアルカリで加水
分解することにより、容易に(日−2−〔p−(β−2
−チエニルビニル)フエニル〕プロピオン酸が得られる
。Further, as the alkali condensing agent, alkali metal hydrides such as sodium hydride, potassium hydride, and lithium hydride, metal amides such as sodium amide and potassium amide, and the like are used. The α-moy alkylated form of the obtained intermediate, that is, the ester form, can be easily converted into (day-2-[p-(β-2
-thienylvinyl)phenyl]propionic acid is obtained.
用いる酸としては、塩酸、硫酸など、また塩基としては
、水酸化ナトリウム、水酸化カリウムなどである。溶媒
としては、メタノール、エタノーノレ、イソプロパノー
ル等のアルコール類、ジオキサン、酢酸、水などを用い
る。加水分解は還流加温を1〜4時間行うことによりな
される。Examples of acids used include hydrochloric acid and sulfuric acid, and examples of bases include sodium hydroxide and potassium hydroxide. As the solvent, alcohols such as methanol, ethanol, isopropanol, dioxane, acetic acid, water, etc. are used. Hydrolysis is carried out by heating under reflux for 1 to 4 hours.
反応終了後、酸による加水分解の場合は水中に投入して
有機溶媒抽出により、また塩基による加水分解の場合は
、有機溶媒を留去して水を注加したのち塩酸などによる
酸性化により結晶を分離する。本発明で得られる0−2
−〔p−(β−2−チエニルビニル)フエニル〕プロピ
オン酸は通常の方法によりナトリウム、カリウム、リチ
ウムなどのアルカリ金属塩、カルシウム、バリウムなど
のアルカリ土類金属塩として得ることもできる。After the reaction is complete, in the case of acid hydrolysis, it is poured into water and extracted with an organic solvent, or in the case of base hydrolysis, the organic solvent is distilled off, water is added, and then acidified with hydrochloric acid etc. to form crystals. Separate. 0-2 obtained by the present invention
-[p-(β-2-thienylvinyl)phenyl]propionic acid can also be obtained as an alkali metal salt such as sodium, potassium, or lithium, or an alkaline earth metal salt such as calcium or barium by a conventional method.
本発明の(ト)−2−〔p−(β−2−チエニルビニル
)フエニル]プロピオン酸のカラゲニン浮腫法によるE
D,O値は23.3〜/Kg,(13.8−39.5)
(経口)であり、フエニルキノン・リツチング法による
ED,O値は14.1mf/l(!?(4.31一46
.2)(経口)である。又、ボルンークロスの方法(G
.V.R.BOrnandM.J.CrOss,J.P
hyslOl.,l68l78(1963))により測
定した(蜀−2−〔p−(β−2−チエニルビニル)フ
エニル〕プロピオン酸のコラーゲンに対する皿小板凝集
阻害作用&人アスピリンに対し、約1.6倍であつた。
本発明化合物の投与量は、投与方法、投与の目的などに
より適宜選択されるが、1日当り1〜30〜/I<f!
を分けて投与することができる。E of (t)-2-[p-(β-2-thienylvinyl)phenyl]propionic acid according to the carrageenan edema method of the present invention
D, O value is 23.3~/Kg, (13.8-39.5)
(oral), and the ED, O value according to the phenylquinone enrichment method is 14.1 mf/l (!? (4.31-46
.. 2) (oral). Also, the Born-Cross method (G
.. V. R. BOrnandM. J. CrOss, J. P
hyslOl. The inhibitory effect of Shu-2-[p-(β-2-thienylvinyl)phenyl]propionic acid on platelet aggregation against collagen was determined by the method (1963) and was approximately 1.6 times that of human aspirin. It was hot.
The dosage of the compound of the present invention is appropriately selected depending on the administration method, purpose of administration, etc., but is 1 to 30/I<f!
can be administered separately.
投与方法は、経口、直腸などである。剤型は錠剤、散剤
、カプセル剤、顆粒、丸剤、シロツプ、坐薬などの好ま
しい剤型で投与しうる。Administration methods include oral, rectal, etc. The dosage form may be administered in a preferred dosage form such as a tablet, powder, capsule, granule, pill, syrup, or suppository.
投与に際しては、薬理学的に許容しうる賦形剤、崩壊剤
、結合剤、滑沢剤、などを加えてもよい。以下、実施例
にて説明する。実施例 1
8−2−〔p−(β−チエニルビニル)フエニル〕プロ
ピオン酸の製造第1工程
エチル(6)−3−〔p−(β−2−チエニルビニル)
−2,3−エポキシブチレートの製造(D−2−(4−
アセチルスチリル)チオフエン、1.25f及びモノク
ロル酢酸エチルエステル、1.35fを無水ベンゼン4
07!Llに溶解する。Upon administration, pharmacologically acceptable excipients, disintegrants, binders, lubricants, etc. may be added. Examples will be described below. Example 1 Production of 8-2-[p-(β-thienylvinyl)phenyl]propionic acid 1st step Ethyl(6)-3-[p-(β-2-thienylvinyl)
-Production of 2,3-epoxybutyrate (D-2-(4-
acetylstyryl) thiophene, 1.25f and monochloroacetic acid ethyl ester, 1.35f, in anhydrous benzene 4
07! Dissolves in Ll.
金属カリウム、0.43f及びt−ブタノール20−よ
り製したカリウム一t−ブトキシド溶液を室温にて窒素
ガス置換下、1時間を要して前記混液中へ滴下する。1
日夜反応後、t−ブタノールを減圧留去し、残渣を氷水
中に投入してエーテル抽出する。A potassium t-butoxide solution prepared from potassium metal, 0.43f, and 20% of t-butanol is dropped into the mixed solution at room temperature over a period of 1 hour under nitrogen gas substitution. 1
After day and night reaction, t-butanol was distilled off under reduced pressure, and the residue was poured into ice water and extracted with ether.
水洗、無水硫酸ナトリウムにて乾燥。本品は結晶化しな
いため、シリカゲルカラムクロマトグラフイ一にて処理
後次の工程に用いる。第2工程
ナトリウム(蜀−3−〔p−(β−2−チエニルビニル
)フエニル〕−2,3−エポキシブチレートの製造先の
反応で得られたエチル(T!)−3−〔p−(β−2−
チエニルビニル)フエニル〕−2,3−エポキシブチレ
ート、1.6yを蒸留エタノール50aに溶解し、金属
ナトリウム116m9を蒸留エタノール107!Llに
溶解して調製したナトリウムエトキシドの溶液を一時に
加え、次いでピペツトより水5滴加えて一日夜室温にて
撹拌し、析出した黄白色沈澱物を濾取し、エタノール、
ジエチルケトンにて洗浄し 黄白色粉末0.65′yを
得る。Wash with water and dry with anhydrous sodium sulfate. Since this product does not crystallize, it is used in the next step after being treated with silica gel column chromatography. 2nd step Ethyl (T!)-3-[p- (β-2-
thienylvinyl)phenyl]-2,3-epoxybutyrate, 1.6y, was dissolved in 50a of distilled ethanol, and 116m9 of metallic sodium was dissolved in 107m of distilled ethanol! A solution of sodium ethoxide prepared by dissolving in Ll was added all at once, then 5 drops of water were added with a pipette, and the mixture was stirred at room temperature for a day and night.
Washing with diethyl ketone gives a yellowish white powder of 0.65'y.
V.)..第3工程
(6)−2−〔p−(β−2−チエニルビニル)フエニ
ル〕プロパナールの製造ナトリウム(ト)−3−〔p−
(β−2−チエニルビニル)フエニル〕−2,3−エポ
キシブチレート、0.57yを、水10CCに懸濁し、
希塩酸溶液を滴下してPH7付近に保ち、油浴中90〜
95℃で2時間加温する。V. ). .. Third step (6) - Production of 2-[p-(β-2-thienylvinyl)phenyl]propanal Sodium (t)-3-[p-
(β-2-thienylvinyl)phenyl]-2,3-epoxybutyrate, 0.57y, was suspended in 10cc of water,
Add diluted hydrochloric acid solution dropwise to keep the pH around 7, and raise the pH to 90~90 in an oil bath.
Incubate at 95°C for 2 hours.
水冷し、析出物を濾取後、クロロホルムにて洗浄、水洗
、乾燥(無水硫酸ナトリウム)第4工程
(蜀−2−〔p−(β−2−チエニルビニル)フエニル
〕プロピオン酸の製造先の工程で得られた0−2−〔p
−(β−2ーチエニルビニル)フエニル〕プロパノール
、1tにエタノール10m1を加え、テトラヒドロフラ
ンを追加して溶解し、水28dに水酸化ナトリウム0.
55f7を溶解した水溶液を滴下し、2時間室温にて撹
拌後、酸化銀を濾別し、濾液を分取する。After cooling with water and collecting the precipitate by filtration, washing with chloroform, washing with water, and drying (anhydrous sodium sulfate) 4th step 0-2-[p obtained in the process
-(β-2-Thienylvinyl)phenyl]To 1 t of propanol, add 10 ml of ethanol, add tetrahydrofuran to dissolve, and add 0.0 ml of sodium hydroxide to 28 d of water.
An aqueous solution in which 55f7 was dissolved was added dropwise, and after stirring at room temperature for 2 hours, silver oxide was filtered off and the filtrate was collected.
濾液よりエタノール留去後、水層をエーテル抽出し、分
離した水層を濃硫酸にて酸性化、エーテル抽出する。参
考例 2
(0−2−〔p−(β−2−チエニルビニル)フエニル
〕プロピオン酸の製造第1工程
()−p−(β−2−チエニルビニノ(ハ)フエニルア
セトチオモルフオリドの製造0−2−(4−アセチルス
チリル)チオフエン1.0tに対し、イオウ0.35f
及びモルフオリン1.01を混合し、水溶上3〜4時間
加温する。After ethanol is distilled off from the filtrate, the aqueous layer is extracted with ether, and the separated aqueous layer is acidified with concentrated sulfuric acid and extracted with ether. Reference Example 2 (Production of 0-2-[p-(β-2-thienylvinyl)phenyl]propionic acid 1st step ()-Production of p-(β-2-thienylvinino(c)phenylacetothiomorphide) 0.35f of sulfur per 1.0t of 0-2-(4-acetylstyryl)thiophene
and Morpholine 1.01 are mixed and heated for 3 to 4 hours until dissolved in water.
結晶析出後、酢酸エチルにて反応混合物を洗浄し、不溶
物を濾取する。第2工程After crystal precipitation, the reaction mixture is washed with ethyl acetate, and insoluble matter is filtered off. 2nd process
Claims (1)
ル)フェニル〕プロピオン酸。 2 (E)−p−(β−2−チエニルビニル)アセトフ
ェノンにαハロゲン化酢酸エステルをアルカリ縮合剤存
在下反応させて対応するグリシド酸エステルとし、これ
をアルカリ存在下加水分解して対応するグリシド酸塩と
し、このものの水溶液を中性附近で加熱して開環脱炭酸
し対応するアルデヒド(次式)とし、これを酸化して対
応する酸とする(E)−2−〔p−(β−2−チエニル
ビニル)フェニル〕プロピオン酸の製造方法。 ▲数式、化学式、表等があります▼[Claims] 1 (E)-2-[p-(β-2-thienylvinyl)phenyl]propionic acid represented by the formula ▲ Numerical formulas, chemical formulas, tables, etc. are available▼. 2 (E)-p-(β-2-thienylvinyl)acetophenone is reacted with α-halogenated acetate in the presence of an alkali condensing agent to obtain the corresponding glycidic acid ester, which is then hydrolyzed in the presence of an alkali to form the corresponding glycidic acid ester. An aqueous solution of this product is heated near neutrality to ring-open and decarboxylate it to form the corresponding aldehyde (formula below), which is then oxidized to form the corresponding acid (E)-2-[p-(β A method for producing -2-thienylvinyl)phenyl]propionic acid. ▲Contains mathematical formulas, chemical formulas, tables, etc.▼
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP1947876A JPS5919550B2 (en) | 1976-02-26 | 1976-02-26 | (E)-2-[p-(β-2-thienylvinyl)phenyl]propionic acid and its production method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP1947876A JPS5919550B2 (en) | 1976-02-26 | 1976-02-26 | (E)-2-[p-(β-2-thienylvinyl)phenyl]propionic acid and its production method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS52105164A JPS52105164A (en) | 1977-09-03 |
| JPS5919550B2 true JPS5919550B2 (en) | 1984-05-07 |
Family
ID=12000434
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP1947876A Expired JPS5919550B2 (en) | 1976-02-26 | 1976-02-26 | (E)-2-[p-(β-2-thienylvinyl)phenyl]propionic acid and its production method |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS5919550B2 (en) |
-
1976
- 1976-02-26 JP JP1947876A patent/JPS5919550B2/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| JPS52105164A (en) | 1977-09-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US3914286A (en) | Lower alkyl esters of p-benzoylphenoxy isobutyric acid | |
| US3668241A (en) | Substituted 1-oxoinden-5-yloxy alkanoic acids | |
| JPH0148911B2 (en) | ||
| Kipnis et al. | 2-Acyloxyacetylthiophenes | |
| US3975432A (en) | Process for preparing 2-(6-methoxy-2-naphthyl)propionic acid | |
| JPS6222740A (en) | Isolation of p-hydroxybenzaldehyde | |
| US3631177A (en) | 3-phenacyl-2-oxoindolines | |
| JPS5919550B2 (en) | (E)-2-[p-(β-2-thienylvinyl)phenyl]propionic acid and its production method | |
| NZ204367A (en) | 2-(6-methoxy-2-naphthyl)propionic acid,preparation by resolution method and glucamine resolving agent | |
| US3506658A (en) | 2-(10-methyl-2-phenoxazinyl)propionic acid | |
| US3450698A (en) | Phenthiazine derivatives | |
| Bailey et al. | 282. Synthetical experiments in the chelidonine–sanguinarine group of the alkaloids. Part II | |
| JPS6019317B2 (en) | Thienothiazine derivative and method for producing the same | |
| US4061668A (en) | Process for the preparation of 2-(4-isobutylphenyl)-propiohydroxamic acid | |
| JPS6116264B2 (en) | ||
| US2720542A (en) | 1-hydroxy-4-methoxy-7-keto-13-methyl-5, 6, 7, 9, 10, 13-hexahydrophenanthrene and processes of preparing the same | |
| US3062834A (en) | Process for preparing thiophencarboxylic acids and their esters | |
| CA1044239A (en) | 6-alkoxy-7-hydroxyquinoline-3-carboxylic acids and derivatives thereof | |
| US3592813A (en) | 3-phenyl-9h-pyridazino(3,4-b)indoles | |
| US3641110A (en) | Phenoxy-aliphatic acids | |
| US3652586A (en) | Process for the production of substituted phenylacetic acids and their esters | |
| JPS62187467A (en) | Novel production of 4-acetylisoquinoline compound | |
| US3691231A (en) | New process for the preparation of 1-indancarboxylic acids | |
| CN110734398A (en) | A kind of new preparation method of 2-chloronicotinic acid | |
| CA1151664A (en) | Optical isomers of 2-(1-halonaphth-2-yloxy) propionic acids and salts and derivatives thereof |